Ligand validation:5JE5

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 5JE5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5JE5_SAH_A_301	97%	35%	0.063	0.979	1.11	1.46	2	3	0	0	100%	1
5JE2_SAH_B_301	99%	41%	0.057	0.986	1.01	1.27	-	3	0	0	100%	1
5JE1_SAH_B_301	98%	41%	0.056	0.981	0.94	1.33	1	4	0	0	100%	1
5JDY_SAH_A_301	97%	34%	0.064	0.978	1.13	1.47	2	6	0	0	100%	1
5JE0_SAH_A_301	96%	39%	0.059	0.97	1.09	1.3	2	3	0	0	100%	1
5JDZ_SAH_B_301	96%	40%	0.066	0.975	1.04	1.3	2	3	0	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8TDR_SAH_B_1001	100%	25%	0.029	0.996	1.26	1.79	3	4	0	0	100%	1
6I73_SAH_A_401	100%	49%	0.028	0.992	0.78	1.16	-	2	0	0	100%	1
8TE4_SAH_B_1001	100%	24%	0.031	0.994	1.26	1.81	3	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.